Michigan lawmakers are proposing a 24% wholesale excise tax on cannabis transfers, adding to current retail taxes. Though expected to raise $420 million for infrastructure, it may drive consolidation, disadvantaging small operators in favor of large firms.
On August 12, 2025, the U.S. Court of Appeals for the Second Circuit issued a key ruling in Variscite NY Four, LLC v. New York State Cannabis Control, with major implications for how interstate commerce affects state cannabis markets.
The DEA has sent a petition to reschedule psilocybin from Schedule I to II, prompting HHS review. This could reshape business regulations, tax implications under IRS 280E, and the future of the psychedelics industry.
Internal Revenue Code Section 280E is beginning to resemble a dried and brittle leaf, clinging to the branch of antiquated federal law long after the season
Another Case for Challenging 280E: HHS’s Authority and the Collapse of Drug Scheduling Powers The cannabis and psychedelics industries are currently subject to one of
The Fight Over Cannabis Rescheduling: Progress, Setbacks, and the Battle Ahead For decades, the Drug Enforcement Administration (DEA) has relied on a rigid five-part test
Challenging 280E: Justifications for Taking Deductions and Amending Tax Returns With recent shifts in federal policy, cannabis businesses face an unprecedented opportunity to challenge 280E.
The Future of Cannabis Investment in a Post-280E Landscape We’re thrilled to announce that Calyx CPA’s own CEO, Justin Botillier, will be speaking at MJBizCon
Advocating for Flexibility: Oregon’s Psilocybin Industry Must Adapt to Stay Ahead To the Oregon psilocybin industry, the upcoming public comment period offers a critical opportunity
